FDA Announces Public Meeting to Discuss Proposed Rule on Pediatric Drug Safety and Effectiveness

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to gather expert input on its proposed rule requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients, following a request for written comments and data on the proposed regulations.